A critical advance in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial cancer inhibitor protein is frequently inactivated in many kinds of malignancies, causing https://tornadosocial.com/story7639143/mini-antibodies-restore-the-p53-protein-new-new-approach-for-cancer-management